Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 6, 2011, Pages 362-368

  Perbellini, Omar ^a   Zamò, Alberto ^a   Colarossi, Sabrina ^b   Zampieri, Francesca ^a   Zoppi, Francesca ^a   Bonadonna, Patrizia ^a   Schena, Donatella ^a   Artuso, Anna ^a   Martinelli, Giovanni ^b   Chilosi, Marco ^a   Pizzolo, Giovanni ^a   Zanotti, Roberta ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CD25; clonal mast cell disorders; flow cytometry; immunohistochemistry; mastocytosis

Indexed keywords

CD2 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DISEASE; BONE MARROW EXAMINATION; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MAST CELL; MONOCLONAL MAST CELL ACTIVATION SYNDROME; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMIC MASTOCYTOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTIGENS, CD2; BIOLOGICAL MARKERS; BONE MARROW CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 80054707327     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20606     Document Type: Article

References (28)

1. Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, Valent P,. Mastocytosis. In:, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p 54.
2. Metcalfe DD,. Mast cells and mastocytosis. Blood 2008; 112: 946-956.
3. Horny H-P, Sotlar K, Valent P,. Mastocytosis: State of the art. Pathobiology 2007; 74; 121-132. (Pubitemid 46985284)
4. Patnaik MM, Rindos M, Kouides PA, Tefferi A, Pardanani A,. Systemic mastocytosis: A concise clinical and laboratory review. Arch Pathol Lab Med 2007; 131: 784-791. (Pubitemid 46726143)
5. Brumsen C, Papapoulos SE, Lentjes EGWM, Kluin PM, Hamdy NAT,. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 2002; 31: 556-561. (Pubitemid 35449696)
6. Chiappetta N, Gruber B,. The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006; 36: 32-36. (Pubitemid 44128594)
7. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123: 680-686.
8. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 2001; 25: 603-625. (Pubitemid 32506768)
9. Valent P, Horny H-P, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb H-J, Krieger O, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007; 31: 727-736. (Pubitemid 46855901)
10. Sonneck K, Florian S, Müllauer L, Wimazal F, Födinger M, Sperr WR, Valent P,. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 2007; 142: 158-164. (Pubitemid 46095928)
11. Akin C,. Anaphylaxis and mast cell disease: What is the risk? Curr Allergy Asthma Rep 2010; 10: 34-38.
12. Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 2010; 125: 1269-1278.e2.
13. Escribano L, Diaz-Agustin B, López A, Núñez López R, García-Montero A, Almeida J, Prados A, Angulo M, Herrero S, Orfao A, et al. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry Part B 2004; 58B: 1-8. (Pubitemid 38332714)
14. Sotlar K, Horny H-P, Simonitsch I, Krokowski M, Aichberger KJ, Mayerhofer M, Printz D, Fritsch G, Valent P,. CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004; 28: 1319-1325. (Pubitemid 39336370)
15. Pardanani A, Kimlinger T, Reeder T, Li C-Y, Tefferi A,. Bone marrow mast cell immunophenotyping in adults with mast cell disease: A prospective study of 33 patients. Leuk Res 2004; 28: 777-783. (Pubitemid 38760039)
16. van Daele PLA, Beukenkamp BS, Geertsma-Kleinekoort WMC, Valk PJM, van Laar JAM, van Hagen PM, van der Velden VHJ,. Immunophenotyping of mast cells: A sensitive and specific diagnostic tool for systemic mastocytosis. Neth J Med 2009; 67: 142-146.
17. Escribano L, Garcia Montero AC, Núñez R, Orfao A, Mastocitosis REd,. Flow cytometric analysis of normal and neoplastic mast cells: Role in diagnosis and follow-up of mast cell disease. Immunol Allergy Clin North Am 2006; 26: 535-547. (Pubitemid 44247538)
18. Krokowski M, Sotlar K, Krauth M-T, Födinger M, Valent P, Horny H-P,. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: Value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol 2005; 124: 560-568. (Pubitemid 41395637)
19. Escribano L, Díaz-Agustín B, Bellas C, Navalón R, Nuñez R, Sperr WR, Schernthaner GH, Valent P, Orfao A,. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 2001; 25: 563-570. (Pubitemid 32506763)
20. Baumgartner C, Sonneck K, Krauth M-T, Kneidinger M, Födinger M, Hauswirth AW, Müllauer L, Valent P,. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry. Eur J Clin Invest 2008; 38: 326-335. (Pubitemid 351489909)
21. Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP, Valent P,. Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001; 25: 529-536. (Pubitemid 32506759)
22. Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NAT, et al. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435-453. (Pubitemid 46817344)
23. Johnson MR, Verstovsek S, Jorgensen JL, Manshouri T, Luthra R, Jones DM, Bueso-Ramos CE, Medeiros LJ, Huh YO,. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Mod Pathol 2009; 22: 50-57.
24. Pardanani A, Kimlinger TK, Reeder TL, Li C-Y, Tefferi A,. Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder. Br J Haematol 2003; 120: 691-694. (Pubitemid 36255872)
25. Teodosio C, García-Montero AC, Jara-Acevedo M, Sánchez-Muñoz L, Alvarez-Twose I, Núñez R, Schwartz LB, Walls AF, Escribano L, Orfao A,. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 2010; 125: 719-726.
26. Lim K-H, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li C-Y, Pardanani A,. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113: 5727-5736.
27. Zanotti R, Bonadonna P, Bonifacio M, Artuso A, Schena D, Rossini M, Perbellini O, Colarossi S, Chilosi M, Pizzolo G,. Isolated bone marrow mastocytosis: An underestimated subvariant of indolent systemic mastocytosis. Haematologica 2011; 96: 482-484.
28. Escribano L, Alvarez-Twose I, Sánchez-Muñoz L, Garcia-Montero A, Núñez R, Almeida J, Jara-Acevedo M, Teodósio C, García-Cosío M, Bellas C, et al. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009; 124: 514-521.